Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Effect of Eplerenone on Endothelial Function in Metabolic Syndrome (MetSyn)

This study has been completed.
Information provided by (Responsible Party):
Roland E. Schmieder, University of Erlangen-Nürnberg Medical School Identifier:
First received: March 17, 2011
Last updated: April 16, 2013
Last verified: April 2013
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2013
  Primary Completion Date: December 2012 (Final data collection date for primary outcome measure)